Role of melatonin in mood disorders and the antidepressant effects of agomelatine

Mortality Associated with Major Depression in a Canadian Community Cohort

(2017) Scott B Patten et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

A Case of Obsessive-Compulsive Disorder Successfully Treated With Agomelatine Monotherapy

(2012) Domenico De Berardis et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Mortality in people with depressive, anxiety and alcohol use disorders in Finland

(2011) Niina Markkula et al.   BRITISH JOURNAL OF PSYCHIATRY

The Emerging Role of Melatonin Agonists in the Treatment of Major Depression: Focus on Agomelatine

(2011) Domenico De Berardis et al.   CNS & Neurological Disorders-Drug Targets

Focus on agomelatine

(2011) Ben Green   CURRENT MEDICAL RESEARCH AND OPINION

Depressive symptoms predict mortality in elderly subjects with chronic heart failure

(2011) Gianluca Testa et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Agomelatine: A narrative review

(2011) Koen Demyttenaere   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients

(2011) Maria-Antonia Quera-Salva et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Mode of action of agomelatine: Synergy between melatonergic and 5-HT2Creceptors

(2011) Giorgio Racagni et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Agomelatine in the Treatment of Major Depressive Disorder

(2010) Sidney H. Kennedy et al.   CNS DRUGS

A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation

(2010) Michele Fornaro et al.   Current Neuropharmacology

Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study

(2010) Anthony Hale et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder

(2010) Siegfried Kasper et al.   JOURNAL OF CLINICAL PSYCHIATRY

Agomelatine in the Treatment of Major Depressive Disorder

(2010) Stephen M. Stahl et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder

(2010) John Zajecka et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Are the Dorsal and Ventral Hippocampus Functionally Distinct Structures?

(2010) Michael S. Fanselow et al.   NEURON

Agomelatine in the treatment of social anxiety disorder

(2010) José Alexandre S. Crippa et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Levels of anxiety and depression as predictors of mortality: the HUNT study

(2009) Arnstein Mykletun et al.   BRITISH JOURNAL OF PSYCHIATRY

Emerging targets for antidepressant therapies

(2009) Jeffrey J Rakofsky et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database☆

(2009) M.C. Serna et al.   EUROPEAN PSYCHIATRY

Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice

(2009) Eleni Païzanis et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Agomelatine Prevents Relapse in Patients With Major Depressive Disorder Without Evidence of a Discontinuation Syndrome

(2009) Guy M. Goodwin et al.   JOURNAL OF CLINICAL PSYCHIATRY

Mechanisms Contributing to the Phase-Dependent Regulation of Neurogenesis by the Novel Antidepressant, Agomelatine, in the Adult Rat Hippocampus

(2009) Amélie Soumier et al.   NEUROPSYCHOPHARMACOLOGY

Bidirectional communication between sleep and circadian rhythms and its implications for depression: Lessons from agomelatine

(2009) Seithikurippu R. Pandi-Perumal et al.   PROGRESS IN NEUROBIOLOGY

Pathophysiology of depression: Role of sleep and the melatonergic system

(2009) Venkataramanujan Srinivasan et al.   PSYCHIATRY RESEARCH

Differences in Medication Adherence and Healthcare Resource Utilization Patterns

(2008) David V Sheehan et al.   CNS DRUGS

Agomelatine: A novel mechanism of antidepressant action involving the melatonergic and the serotonergic system

(2008) Luis San et al.   EUROPEAN PSYCHIATRY

Circadian rhythm disturbances in depression

(2008) Anne Germain et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Efficacy of Agomelatine in Generalized Anxiety Disorder

(2008) Dan J. Stein et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

A Double-Blind Comparison of Sexual Functioning, Antidepressant Efficacy, and Tolerability Between Agomelatine and Venlafaxine XR

(2008) Sidney H. Kennedy et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Major depression: emerging therapeutics

(2008) Srijan Sen et al.   MOUNT SINAI JOURNAL OF MEDICINE